5
2

Securing America’s Drug Supply from Communist China Act

5/12/2026, 2:00 PM

Summary of Bill S 4327

The bill titled "A bill to require regulatory review of pharmaceutical products from Chinese entities, and for other purposes," was introduced in the 119th Congress on April 16, 2026. The bill aims to mandate regulatory review processes specifically for pharmaceutical products originating from Chinese entities, likely focusing on ensuring safety, efficacy, and compliance standards for such products.

Current Status of Bill S 4327

Bill S 4327 is currently in the status of Bill Introduced since April 16, 2026. Bill S 4327 was introduced during Congress 119 and was introduced to the Senate on April 16, 2026.  Bill S 4327's most recent activity was Read twice and referred to the Committee on Health, Education, Labor, and Pensions. as of April 16, 2026

Bipartisan Support of Bill S 4327

Total Number of Sponsors
1
Democrat Sponsors
0
Republican Sponsors
1
Unaffiliated Sponsors
0
Total Number of Cosponsors
0
Democrat Cosponsors
0
Republican Cosponsors
0
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill S 4327

Primary Policy Focus

Health

Alternate Title(s) of Bill S 4327

A bill to require regulatory review of pharmaceutical products from Chinese entities, and for other purposes.
A bill to require regulatory review of pharmaceutical products from Chinese entities, and for other purposes.

Comments

Sponsors and Cosponsors of S 4327

Latest Bills

Foster Youth Housing Opportunity Act
Bill HR 7432May 14, 2026
A bill to amend the National Defense Authorization Act for Fiscal Year 2021 to prohibit certain institutions of higher education from receiving research and development awards, and for other purposes.
Bill S 4424May 14, 2026
Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Fair Credit Reporting; Permissible Purposes for Furnishing, Using, and Obtaining Consumer Reports".
Bill HJRES 165May 14, 2026
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Fair Credit Reporting; Permissible Purposes for Furnishing, Using, and Obtaining Consumer Reports".
Bill SJRES 145May 14, 2026
Amending the Rules of the House of Representatives to prohibit Members, officers, and employees of the House of Representatives from participating in prediction markets in certain cases, and for other purposes.
Bill HRES 1248May 14, 2026
Ending Discrimination in Government Contracting Act
Bill HR 8511May 14, 2026
Ending Discrimination in Government Contracting Act
Bill S 4390May 14, 2026
To designate the facility of the United States Postal Service located at 201 East Grant Avenue in Georgetown, Ohio, as the "Ulysses S. Grant Post Office Building".
Bill HR 7809May 14, 2026
To designate the facility of the United States Postal Service located at 111 South Tremont Street in Tremonton, Utah, as the "Sorensen-Estrada Post Office".
Bill HR 8225May 14, 2026
To designate the facility of the United States Postal Service located at 189 East Main Street in Xenia, Ohio, as the "Gilman 'Gil' Whitney Post Office Building".
Bill HR 8193May 14, 2026